Clinical Characteristics, Surgical Management, and Prognostic Factors of Medullary Thyroid Carcinoma: A Retrospective, Single-Center Study

医学 阶段(地层学) 恶性肿瘤 淋巴血管侵犯 累积发病率 内科学 单中心 多元分析 回顾性队列研究 甲状腺癌 淋巴结 单变量分析 胃肠病学 甲状腺 癌症 转移 队列 古生物学 生物
作者
Xin Wu,Binglu Li,Congyi Zheng
出处
期刊:Technology in Cancer Research & Treatment [SAGE Publishing]
卷期号:21: 153303382210784-153303382210784 被引量:5
标识
DOI:10.1177/15330338221078435
摘要

Purpose: Medullary thyroid carcinoma (MTC) is a rare neuroendocrine malignancy with relatively early lymphatic metastatic spread. The clinical features of MTC remain controversial owing to the low incidence rate. This study aimed to analyze the clinical characteristics, prognostic factors, and long-term follow-up of MTC. Methods: Medical records of MTC patients treated at our hospital between December 2000 and November 2020 were reviewed retrospectively. Clinicopathologic features of MTC were analyzed using univariate and multivariate analyses. Cumulative survival rates were estimated using the Kaplan-Meier method. Results: In total, 152 patients with MTC were included. The rates of central and lateral lymph node metastases (LNM) were 52.0% and 42.8%, respectively. All patients were followed up with a median follow-up time of 43.5 (17.0−76.3) months. Univariate and multivariate analyses identified two independent factors associated with progressive disease. They were lateral LNM (p < 0.001) and lymph node ratio (LNR) >1/3 (p = 0.009). The 5-, 10-, and 15-year cumulative overall survival (OS) rates of MTC were 88.2%, 83.1%, and 76.2%, respectively. The 5-, 10-, and 15-year cumulative disease-free survival (DFS) rates were 61.8%, 48.6%, and 38.2%, respectively. Patients with stage I, II, and III disease had significantly longer OS and DFS than those with stage IV disease (p < 0.001). Conclusion: MTC is a rare endocrine malignancy and LNM is common. Patients with lateral LNM and LNR >1/3 are more likely to develop progressive disease. The long-term OS rates of MTC are good, but long-term DFS rates are poor.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
思源应助乘风采纳,获得10
刚刚
PT177245发布了新的文献求助10
1秒前
1秒前
3秒前
4秒前
4秒前
陈某关注了科研通微信公众号
5秒前
zcy完成签到,获得积分10
6秒前
EgoElysia关注了科研通微信公众号
6秒前
天天快乐应助未道采纳,获得10
7秒前
归尘发布了新的文献求助10
7秒前
8秒前
隐形曼青应助科研通管家采纳,获得10
8秒前
猪猪hero应助科研通管家采纳,获得10
8秒前
orixero应助科研通管家采纳,获得10
9秒前
情怀应助科研通管家采纳,获得10
9秒前
pluto应助科研通管家采纳,获得10
9秒前
9秒前
田様应助科研通管家采纳,获得10
9秒前
9秒前
香蕉觅云应助科研通管家采纳,获得10
9秒前
9秒前
pluto应助科研通管家采纳,获得10
9秒前
彭于彦祖应助科研通管家采纳,获得50
9秒前
科研通AI5应助科研通管家采纳,获得10
9秒前
坦率的匪应助科研通管家采纳,获得10
10秒前
10秒前
李健应助科研通管家采纳,获得10
10秒前
Bio应助科研通管家采纳,获得150
10秒前
recovery应助科研通管家采纳,获得10
10秒前
科研通AI2S应助科研通管家采纳,获得10
10秒前
10秒前
无花果应助科研通管家采纳,获得10
10秒前
科研通AI5应助科研通管家采纳,获得10
10秒前
斯文败类应助科研通管家采纳,获得10
10秒前
完美世界应助科研通管家采纳,获得10
11秒前
Orange应助科研通管家采纳,获得10
11秒前
爆米花应助科研通管家采纳,获得10
11秒前
11秒前
科研通AI5应助科研通管家采纳,获得30
11秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3988827
求助须知:如何正确求助?哪些是违规求助? 3531197
关于积分的说明 11252739
捐赠科研通 3269830
什么是DOI,文献DOI怎么找? 1804815
邀请新用户注册赠送积分活动 881915
科研通“疑难数据库(出版商)”最低求助积分说明 809028